Examkin

Question

Difficulty: Very hardDepressive Disorders

A 34-year-old woman comes to the clinic reporting a 6-week history of pervasive sadness, frequent tearfulness, and profound fatigue. She states that her arms and legs feel "like they are made of lead" and she is sleeping up to 14 hours a day. She feels immense guilt about being an inadequate mother to her 4-month-old infant, whom she is exclusively breastfeeding. Three years ago, the patient was prescribed paroxetine for generalized anxiety. Two weeks after starting the medication, she became unusually energetic, slept only 2 hours a night without feeling tired, and began making impulsive, large investments in cryptocurrency, which depleted her savings. The paroxetine was immediately discontinued, but her hyperactive and grandiose state persisted for another 5 weeks before gradually resolving. She has not taken any psychiatric medications since that time. Vital signs and physical examination are unremarkable. Which of the following is the most appropriate pharmacotherapy for this patient's current symptoms?

  1. Initiate quetiapine therapyAnswer
  2. B
    Initiate sertraline therapy
  3. C
    Initiate lithium carbonate therapy
  4. D
    Initiate brexanolone infusion
  5. E
    Initiate venlafaxine therapy

Answer

Initiate quetiapine therapy
The patient's current presentation of a major depressive episode with atypical features must be viewed in the context of her psychiatric history. She previously experienced a full manic episode while on paroxetine. Crucially, the mania persisted for 5 weeks after paroxetine cessation. According to DSM-5 criteria, a manic episode that emerges during antidepressant treatment but persists at a fully syndromal level beyond the physiological effect of that drug constitutes a true manic episode, establishing a diagnosis of Bipolar I Disorder. Consequently, her current state is acute bipolar depression. Antidepressant monotherapy is contraindicated. Second-generation antipsychotics like quetiapine are first-line for bipolar depression. Furthermore, because she is exclusively breastfeeding, quetiapine is an ideal choice due to its very low excretion into breast milk, whereas other agents like lithium carry high risks of infant toxicity.

Step-by-Step Solution

1
Analyze the current clinical presentation.
The patient is experiencing a major depressive episode with atypical features (hypersomnia, leaden paralysis) occurring 4 months postpartum.
Establishing the current syndrome is the first step in guiding psychiatric management.
2
Evaluate the past psychiatric history for exclusionary criteria.
Three years ago, she had a full manic episode (decreased sleep, grandiosity, impulsivity) triggered by paroxetine.
A history of mania completely changes the management of a depressive episode by shifting the diagnosis from Major Depressive Disorder to a Bipolar Disorder.
3
Apply DSM-5 duration rules for medication-induced symptoms.
Because the manic symptoms persisted for 5 weeks after the short-acting paroxetine was discontinued, they extended beyond the physiological effect of the drug.
A manic episode persisting beyond the physiological effect of an antidepressant establishes a diagnosis of true Bipolar I Disorder, rather than just medication-induced mania.
4
Determine the appropriate class of medication for the current episode.
The patient requires treatment for acute bipolar depression. Antidepressant monotherapy must be avoided to prevent a manic switch.
Treating bipolar depression requires mood stabilizers or specific atypical antipsychotics, not standard SSRIs/SNRIs alone.
5
Filter suitable medications based on the patient's lactation status.
Lithium poses toxicity risks to the infant. Quetiapine is efficacious for bipolar depression and safe during breastfeeding.
The patient is exclusively breastfeeding, mandating a medication with low breast milk transfer and known neonatal safety.

Key Concept

Differentiation of Bipolar I Disorder from unipolar depression based on historical antidepressant-induced mania, and selection of safe bipolar pharmacotherapy during lactation.
Estimated Time:2m 0s
Rate this question

Topics

Depressive Disorders

More questions from this topic